Neuburgh Advisers’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$511K Buy
34,204
+612
+2% +$9.96K 0.02% 459
2019
Q2
$806K Sell
33,592
-40,154
-54% -$1.18M 0.03% 357
2019
Q1
$2.74M Sell
73,746
-170,510
-70% -$6.2M 0.09% 181
2018
Q4
$6.89M Sell
244,256
-82,450
-25% -$2.61M 0.27% 77
2018
Q3
$12.9M Buy
326,706
+51,850
+19% +$2.27M 0.42% 52
2018
Q2
$12.2M Buy
274,856
+18,734
+7% +$932K 0.41% 54
2018
Q1
$12.5M Buy
256,122
+25,228
+11% +$1.26M 0.44% 58
2017
Q4
$11.6M Buy
230,894
+92,650
+67% +$4.85M 0.41% 60
2017
Q3
$7M Buy
138,244
+114,002
+470% +$5.38M 0.26% 83
2017
Q2
$919K Buy
24,242
+12,716
+110% +$502K 0.03% 284
2017
Q1
$444K Sell
11,526
-850
-7% -$25.6K 0.02% 375
2016
Q4
$273K Buy
+12,376
New +$254K 0.01% 421

Other funds holding CC

Neuburgh Advisers's CC Position: Q3 2019 in Review

Neuburgh Advisers increased its Chemours (CC) stake by 1.8% in Q3 2019, buying an estimated $9.96K and bringing the position to 34,204 shares worth $511K. The position accounts for 0.02% of the portfolio, ranked #459.

Neuburgh Advisers first reported a position in CC in Q4 2016 and has held it in 12 quarters since. The position peaked at $12.9M in Q3 2018. 418 funds tracked by Wall St. Rank hold CC as of Q3 2019.

  • Neuburgh Advisers held 34,204 shares of Chemours worth $511K as of Q3 2019.
  • Neuburgh Advisers bought 612 Chemours shares in Q3 2019, an estimated $9.96K.
  • Chemours made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #459 holding.
  • Neuburgh Advisers first reported a position in Chemours in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Chemours position peaked at $12.9M in Q3 2018.
  • 418 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.